Excellent! I look forward to reading it. There is a wealth of information to share on HGEN and I'm excited to watch thier growth in Covid-19, Car-T, CMML, GVHD and Glioblastoma with Ifabotuzumab. Mayo Clinic support and positive data along with Patents and strong Institutions invested here.